HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

A protocol for foscarnet administration.

Abstract
Recently the Food and Drug Administration approved the drug foscarnet for treatment of cytomegalovirus retinitis. As with many other medications, foscarnet has some serious side effects and needs to be administered according to a standardized protocol. This article presents a protocol that was developed for the safe and appropriate delivery of foscarnet.
AuthorsD G Smith Jr, C M Handy
JournalJournal of intravenous nursing : the official publication of the Intravenous Nurses Society (J Intraven Nurs) 1992 Sep-Dec Vol. 15 Issue 5 Pg. 274-7 ISSN: 0896-5846 [Print] UNITED STATES
PMID1336798 (Publication Type: Journal Article)
Chemical References
  • Foscarnet
Topics
  • Clinical Protocols (standards)
  • Cytomegalovirus Infections (drug therapy, nursing)
  • Foscarnet (administration & dosage, adverse effects)
  • Humans
  • Patient Care Planning
  • Retinitis (drug therapy, nursing)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: